The Institut Pasteur and Merieux Alliance Company Profile

21:52 EDT 25th October 2014 | BioPortfolio

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of diseases through biological research, education and public-health activities. Close to 2,600 people work on its campus in Paris, where a large part of its research activities are devoted to infectious diseases and 10% focuses on AIDS research. The Paris institute is the heart of an International Network made up that unites 30 institutes across all five continents. Over a period of 120 years, 10 Institut Pasteur researchers have received the Nobel Prize, the latest of these in 2008, when it was awarded to Professors Francoise Barre-Sinoussi and Luc Montagnier for the discovery of the Aids virus.


News Articles [690 Associated News Articles listed on BioPortfolio]

Sanofi Pasteur MSD: Who’s running the show

Formed through the merger of Sanofi Pasteur and Merck, Sanofi Pasteur MSD ranks as one of the top vaccine companies in the world. Marketing some of the best selling vaccines developed between the two ...

Institut Pasteur de Montevideo, Genomic Medicine Institute-Seoul National University, and Macrogen Launch Urugenomes Project to Decode the Genome of Uruguyan Population

Institut Pasteur de Montevideo (Uruguay), Genomic Medicine Institute- Seoul National University (GMI-SNU, South Korea) and Macrogen Inc. ( KRX 038290) (South Korea) have announced...

Sanofi Pasteur, Immune Design Enter HSV Immune Therapy Alliance

Will explore various combinations of agents leveraging Immune Design's GLAAS platform

Sanofi Pasteur Posts Positive C. Diff Vaccine Findings

Sanofi Pasteur, the vaccines division of Sanofi, presented Phase 2 trial (H-030-012) results for an investigational vaccine for the prevention of Cl

Ebola virus disease update - Senegal

On 30 August 2014, Senegal’s Ministry of Public Health and Social Affairs provided WHO with details about a case of Ebola virus disease (EVD) announced in that country on 29 August. WHO has also re...

Sanofi Pasteur, CureVac to Develop mRNA-based Prophylactic Vaccine

CureVac, a German clinical-stage biopharmaceutical company, announced the execution of an exclusive license agreement with Sanofi

KaloBios Regains Global Rights To KB001-A, Ends Deal With Sanofi Pasteur

PARIS (dpa-AFX) - Shares of KaloBios Pharmaceuticals, Inc. (KBIO) tumbled almost 12 percent in extended trades Monday after the company said that Sanofi Pasteur has agreed to terminate their colla...

Astrazeneca und das Max-Plnck-Institut vereinbaren gemeinsame Forschungseinheit / Grundlagenforschung für Herzkreislauf- und Stoffwechsel-Erkrankungen

Dortmund/Mölndal/Wedel (ots) - Das forschende Pharmaunternehmen AstraZeneca und das Max-Planck-Institut für molekulare Physiologie haben heute bekanntgegeben, dass sie eine gemeinsame Forschungsein....

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Another year of microbial pathogens and the host immune response.

Dear prudence.

Article highlight based on "Th2-type inflammation under conditions of pre-existing chronic disease is associated with liver damage in patients with avian influenza H7N9 virus" by Jiankang Han et al.

Validation of a Measure of Alliance for an Adolescent Inpatient Setting.

The link between alliance and treatment outcome is robust. Nevertheless, few, if any, self-report measures exist to assess the alliance between hospitalized adolescents and their treatment team as a w...

Tuberculosis in Papua New Guinea: from yesterday until today.

Little is known about the situation of tuberculosis in Papua New Guinea despite its high TB burden, emerging drug resistance and rising HIV co-infection. This review gives an overview on the current s...

Child, Caregiver, and Therapist Perspectives on Therapeutic Alliance in Usual Care Child Psychotherapy.

This study examined the temporal stability and cross-informant agreement on multiple perspectives of child and caregiver alliance with therapists in usual care psychotherapy. Baseline predictors of al...

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Intervention to Reduce Injection Drug Use

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the b...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTaP-IPV combined vaccines as a three-dose primary vaccination at 2, 4 and 6 months of age ...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Companies [475 Associated Companies listed on BioPortfolio]

The Institut Pasteur and Merieux Alliance

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of...

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it ...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

Parteurop

Parteurop is a partner of choice in the life sciences business thanks to its seasoned, experienced team and its international network.Parteurop’s core practices are focused on consulting, private eq...

More Information about "The Institut Pasteur and Merieux Alliance" on BioPortfolio

We have published hundreds of The Institut Pasteur and Merieux Alliance news stories on BioPortfolio along with dozens of The Institut Pasteur and Merieux Alliance Clinical Trials and PubMed Articles about The Institut Pasteur and Merieux Alliance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institut Pasteur and Merieux Alliance Companies in our database. You can also find out about relevant The Institut Pasteur and Merieux Alliance Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record